A deep sternal wound infection caused by Ureaplasma urealyticum

References

1. Bosshard P. P., Kronenberg A., Zbinden R., Ruef C., Bottger E. C., Altwegg M. 2003; Etiologic diagnosis of infective endocarditis by broad-range polymerase chain reaction: a 3-year experience. Clin Infect Dis 37:167–172 [CrossRef]
   [Google Scholar]
2. Cordtz J., Jensen J. S. 2006; Disseminated Ureaplasma urealyticum infection in a hypo-gammaglobulinaemic renal transplant patient. Scand J Infect Dis 38:1114–1117 [CrossRef]
   [Google Scholar]
3. Garcia-de-la-Fuente C., Minambres E., Ugalde E., Saez A., Martinez-Martinez L., Farinas M. C. 2008; Post-operative mediastinitis, pleuritis and pericarditis due to Mycoplasma hominis and Ureaplasma urealyticum with a fatal outcome. J Med Microbiol 57:656–657 [CrossRef]
   [Google Scholar]
4. Geissdorfer W., Sandner G., John S., Gessner A., Schoerner C., Schroppel K. 2008; Ureaplasma urealyticum meningitis in an adult patient. J Clin Microbiol 46:1141–1143 [CrossRef]
   [Google Scholar]
5. Kenny G. E., Cartwright F. D. 2001; Susceptibilities of Mycoplasma hominis , M. pneumoniae , and Ureaplasma urealyticum to GAR-936, dalfopristin, dirithromycin, evernimicin, gatifloxacin, linezolid, moxifloxacin, quinupristin-dalfopristin, and telithromycin compared to their susceptibilities to reference macrolides, tetracyclines, and quinolones. Antimicrob Agents Chemother 45:2604–2608 [CrossRef]
   [Google Scholar]
6. Krausse R., Schubert S. 2010; In-vitro activities of tetracyclines, macrolides, fluoroquinolones and clindamycin against Mycoplasma hominis and Ureaplasma ssp. isolated in Germany over 20 years. Clin Microbiol Infect 16: (in press
   [Google Scholar]
7. Mauermann W. J., Sampathkumar P., Thompson R. L. 2008; Sternal wound infections. Best Pract Res Clin Anaesthesiol 22:423–436 [CrossRef]
   [Google Scholar]
8. Pereyre S., Gonzalez P., de Barbeyrac B., Darnige A., Renaudin H., Charron A., Raherison S., Bebear C., Bebear C. M. 2002; Mutations in 23S rRNA account for intrinsic resistance to macrolides in Mycoplasma hominis and Mycoplasma fermentans and for acquired resistance to macrolides in M. hominis . Antimicrob Agents Chemother 46:3142–3150 [CrossRef]
   [Google Scholar]
9. Pigrau C., Almirante B., Gasser I., Pahissa A. 1995; Sternotomy infection due to Mycoplasma hominis and Ureaplasma urealyticum . Eur J Clin Microbiol Infect Dis 14:597–598 [CrossRef]
   [Google Scholar]
10. Robertson J. A., Stemke G. W., Davis J. W. Jr, Harasawa R., Thirkell D., Kong F., Shepard M. C., Ford D. K. et al. 2002; Proposal of Ureaplasma parvum sp. nov. and emended description of Ureaplasma urealyticum (Shepard et al 1974, Robertson et al. 2001. Int J Syst Evol Microbiol 52:587–597
    [Google Scholar]
11. Waites K. B., Taylor-Robinson D. 2007; Mycoplasma and ureaplasma. In Manual of Clinical Microbiology, 9th edn. pp 1004–1020 Edited by Murray P. R., Baron E. J., Jorgensen J. H., Landry M. L., Pfaller M. A. Washington, DC: American Society for Microbiology;
    [Google Scholar]
12. Waites K. B., Katz B., Schelonka R. L. 2005; Mycoplasmas and ureaplasmas as neonatal pathogens. Clin Microbiol Rev 18:757–789 [CrossRef]
    [Google Scholar]
13. Walkty A., Lo E., Manickam K., Alfa M., Xiao L., Waites K. 2009; Ureaplasma parvum as a cause of sternal wound infection. J Clin Microbiol 47:1976–1978 [CrossRef]
    [Google Scholar]
14. Wilcox M. H. 2009; The tide of antimicrobial resistance and selection. Int J Antimicrob Agents 34:S6–S10
    [Google Scholar]
15. Xie X., Zhang J. 2006; Trends in the rates of resistance of Ureaplasma urealyticum to antibiotics and identification of the mutation site in the quinolone resistance-determining region in Chinese patients. FEMS Microbiol Lett 259:181–186 [CrossRef]
    [Google Scholar]